This test is used to assess risk of hereditary breast and ovarian cancer syndrome and other BRCA1- and BRCA2-associated hereditary cancers.
My Recent Searches
- No Recent Search.
My Tests Viewed
- No Test Viewed.
Showing related guides for “BRCAvantage , Comprehensive” 1 - 4 of 4
This test guide is intended to help the clinician select the most appropriate test for each patient.
This Clinical Focus is intended to help the clinician assess and select individuals for hereditary cancer-associated genetic testing. It is also intended as a resource to help with appropriate test selection and result interpretation.
This document summarizes the National Comprehensive Cancer Network (NCCN) genetic testing criteria for hereditary breast and ovarian cancer syndrome. That is, it provides patient eligibility criteria for BRCA1/BRCA2 genetic testing.
* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.